Delivery Order SPE2DB20D1109-SPE2DB25FN94M
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,592.12 firm-fixed-price delivery order contract is for the supply of the prescription medication Rinvoq ER 45 mg tablets. The contract has an ultimate completion date of April 22, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Rinvoq ER 30 mg tablets. The contract has a ceiling value of $7,775.50 and a period of performance through April 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,111.66 firm fixed-price delivery order is for the supply of the medication RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of April 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,290.54, is for the delivery of the prescription medication Rinvoq ER 30 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a larger...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $57,407.07 delivery order contract is for the supply of the prescription medication RINVOQ ER 15 MG TABLET, a non-set-aside award. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rinvoq ER 30 MG Tablet, a prescription medication, with a ceiling value of $23,125.79 and a period of performance through April 2025. The contract is a firm fixed-price delivery order, and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $55,597.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Rinvoq ER 45 mg tablets, a medication used to treat certain medical conditions. This contract is not designated as a set-aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,579.05, is for the supply of the medication Rinvoq ER 45 mg tablets. The contract has an ultimate completion date of June 11, 2024 and uses a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,710.23 firm fixed-price delivery order is for Rinvoq ER 30 mg tablets, a medication used to treat various medical conditions. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $17,141.89, is for the delivery of the prescription drug Rinvoq ER 15 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...